0 0
0 0

References-Products-Nutrients

Posted on 13 May 2021 by Dr. Rodney Lopez MBBS ( USyd ) GradCertNutriMed (RMIT)
Category:
  1. Singh, M. (2005). “Essential fatty acids, DHA and human brain.” Indian Journal of Pediatrics 72(3): 239-242.
  2. Sanders, L.M. and Zeisel, S.H., 2007. Choline: dietary requirements and role in brain development. Nutrition today, 42(4), p.181.
  3. Middleton, P., Gomersall, J.C., Gould, J.F., Shepherd, E., Olsen, S.F. and Makrides, M., 2018. Omega‐3 fatty acid addition during pregnancy. Cochrane Database of Systematic Reviews, (11).
  4. Dean, O., Giorlando, F. and Berk, M., 2011. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. Journal of psychiatry & neuroscience: JPN, 36(2), p.78.
  5. Imai, S.-i. and L. Guarente (2014). “NAD+ and sirtuins in aging and disease.” Trends in cell biology 24(8): 464-471.
  6. Bonkowski, M. S. and D. A. Sinclair (2016). “Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds.” Nature Reviews Molecular Cell Biology.
  7. Hao, J., Ni, X., Giunta, S., Wu, J., Shuang, X., Xu, K., Li, R., Zhang, W. and Xia, S., 2020. Pyrroloquinoline quinone delays inflammaging induced by TNF‐α through the p16/p21 and Jagged1 signalling pathways. Clinical and Experimental Pharmacology and Physiology, 47(1), pp.102-110.
  8. Dibaba, D., et al. (2015). “Magnesium intake and incidence of pancreatic cancer: the VITamins and Lifestyle study.” British journal of cancer.
  9. https://www.hsph.harvard.edu/nutritionsource/multivitamin/
  10. Ames, B. N. (2006). “Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage.” Proceedings of the National Academy of Sciences 103(47): 17589-17594.
  11. Rosas‐Ballina, M. and Tracey, K.J., 2009. Cholinergic control of inflammation. Journal of internal medicine, 265(6), pp.663-679.
  12. Pavlov, V. A. and K. J. Tracey (2012). “The vagus nerve and the inflammatory reflex—linking immunity and metabolism.” Nature Reviews Endocrinology 8(12): 743.
  13. Bullmore, E., 2018. The inflamed mind: a radical new approach to depression. Picador.
  14. Lund, E. K., et al. (1999). “Effects of dietary fish oil supplementation on the phospholipid composition and fluidity of cell membranes from human volunteers.” Annals of Nutrition and Metabolism 43(5): 290-300.
  15. Nelles, J.L., Hu, W.Y. and Prins, G.S., 2011. Estrogen action and prostate cancer. Expert review of endocrinology & metabolism, 6(3), pp.437-451.
  16. Fahey, J.W. and Talalay, P., 1999. Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes. Food and Chemical Toxicology, 37(9-10), pp.973-979.
  17. Sinclair, D.A. and LaPlante, M.D., 2019. Lifespan: Why We Age—and Why We Don’t Have To. Atria Books.
  18. Hesselink, J.M.K. and Hekker, T.A., 2012. Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series. Journal of Pain Research, 5, p.437.
  19. Gabrielsson, L., Mattsson, S. and Fowler, C.J., 2016. Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy. British journal of clinical pharmacology, 82(4), pp.932-942.
  20. De Filippis, D., Luongo, L., Cipriano, M., Palazzo, E., Cinelli, M.P., de Novellis, V., Maione, S. and Iuvone, T., 2011. Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats. Molecular pain, 7, pp.1744-8069.
  21. Liang, Y., Xie, H., Wu, J., Liu, D. and Yao, S., 2018. Villainous role of estrogen in macrophage-nerve interaction in endometriosis. Reproductive Biology and Endocrinology, 16(1), p.122.
  22. Hunt, C.D. and Idso, J.P., 1999. Dietary boron as a physiological regulator of the normal inflammatory response: a review and current research progress. The Journal of Trace Elements in Experimental Medicine: The Official Publication of the International Society for Trace Element Research in Humans, 12(3), pp.221-233.
  23. Donoiu, I., Militaru, C., Obleagă, O., Hunter, J.M., Neamţu, J., Biţă, A., Scorei, I.R. and Rogoveanu, O.C., 2018. Effects of boron-containing compounds on cardiovascular disease risk factors–a review. Journal of Trace Elements in Medicine and Biology, 50, pp.47-54
  24. Altuwaijri, S., 2012. Role of prostate specific antigen (PSA) in pathogenesis of prostate cancer.
  25. Hesselink, J.M.K. and Hekker, T.A., 2012. Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series. Journal of Pain Research, 5, p.437. (18)
  26. Gabrielsson, L., Mattsson, S. and Fowler, C.J., 2016. Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy. British journal of clinical pharmacology, 82(4), pp.932-942. (19)
  27. De Filippis, D., Luongo, L., Cipriano, M., Palazzo, E., Cinelli, M.P., de Novellis, V., Maione, S. and Iuvone, T., 2011. Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats. Molecular pain, 7, pp.1744-8069. (20)
  28. Liang, Y., Xie, H., Wu, J., Liu, D. and Yao, S., 2018. Villainous role of estrogen in macrophage-nerve interaction in endometriosis. Reproductive Biology and Endocrinology, 16(1), p.122. (21)
  29. Pizzorno, L., 2015. Nothing boring about boron. Integrative Medicine: A Clinician’s Journal, 14(4), p.35.
  30. Kim, J., et al. (2019). “Association of Vitamin A Intake With Cutaneous Squamous Cell Carcinoma Risk in the United States.” JAMA dermatology.
  31. Osher, E., Weisinger, G., Limor, R., Tordjman, K. and Stern, N., 2006. The 5 lipoxygenase system in the vasculature: emerging role in health and disease. Molecular and cellular endocrinology, 252(1-2), pp.201-206.
  32. Gommers, L.M., Hoenderop, J.G., Bindels, R.J. and de Baaij, J.H., 2016. Hypomagnesemia in type 2 diabetes: a vicious circle?. Diabetes, 65(1), pp.3-13.
  33. Hruby, A., O’Donnell, C.J., Jacques, P.F., Meigs, J.B., Hoffmann, U. and McKeown, N.M., 2014. Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study. JACC: Cardiovascular Imaging, 7(1), pp.59-69.
  34. Slutsky, I., et al. (2010). “Enhancement of learning and memory by elevating brain magnesium.” Neuron 65(2): 165-177.
  35. Liu, G., Weinger, J.G., Lu, Z.L., Xue, F. and Sadeghpour, S., 2016. Efficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults: a randomized, double-blind, placebo-controlled trial. Journal of Alzheimer’s Disease, 49(4), pp.971-990.
  36. Guo, W., Nazim, H., Liang, Z. and Yang, D., 2016. Magnesium deficiency in plants: An urgent problem. The Crop Journal, 4(2), pp.83-91.
  37. Cordain, L., 1999. Cereal grains: humanity’s double-edged sword. World review of nutrition and dietetics, 84, pp.19-19.
  38. Maresz, K., 2015. Proper calcium use: vitamin K2 as a promoter of bone and cardiovascular health. Integrative Medicine: A Clinician’s Journal, 14(1), p.34.
  39. Theuwissen, E., Magdeleyns, E.J., Braam, L.A.J.L.M., Teunissen, K.J., Knapen, M.H., Binnekamp, I.A.G., van Summeren, M.J.H. and Vermeer, C., 2014. Vitamin K status in healthy volunteers. Food & function, 5(2), pp.229-234.
  40. Strijdom, H., Chamane, N. and Lochner, A., 2009. Nitric oxide in the cardiovascular system: a simple molecule with complex actions. Cardiovascular journal of Africa, 20(5), p.303.
  41. Godsland, I.F., 2010. Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clinical science, 118(5), pp.315-332.
  42. Stix, G., 2007. A malignant flame. Scientific American, 297(1), pp.60-67.
  43. Kim, D.J., Xun, P., Liu, K., Loria, C., Yokota, K., Jacobs, D.R. and He, K., 2010. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes care, 33(12), pp.2604-2610.
  44. Australian Health Survey: Usual Nutrient Intake, 2011-12
  45. Norton, L. and G. J. Wilson (2009). “Optimal protein intake to maximize muscle protein synthesis.” AgroFood industry hi-tech 20: 54-57.
  46. Blackburn, E. H. (2017). The Telomere Effect, Orion Spring.
  47. Matulka, R.A., Lyon, M.R., Wood, S., et al. (2009). The safety of PolyGlycopleX® (PGX®) as shown in a 90-day rodent feeding study. Nutrition Journal, 8,1.
  48. Carabin, I.G., Lyon, M.R., Wood, S., et al. (2009). Supplementation of the diet with the functional fibre PolyGlycoplex® is well tolerated by healthy subjects in a clinical trial.Nutrition Journal, 8, 9.
  49. Marone, P.A., Lyon, M.R., Gahler, R., et al. (2009). Genotoxicity studies of PolyGlycopleX® (PGX®): a novel dietary fibre. International Journal of Toxicology, 28(4), 318-331.
  50. Carabin, I., Gahler, R.J., Lyon, M.R., et al. (2010). Correlating Preclinical, clinical and post market surveillance data: a case study. Nutraceutical Magazine, 6(5), 12-17.
  51. Brand-Miller, J.C., Atkinson, F.S., Gahler, R.J., et al. Effects of added PGX®, a novel functional fibre, on the glycaemic index of starchy foods. British Journal of Nutrition, 2011,10:1-4.
  52. Dibaba, D., et al. (2015). “Magnesium intake and incidence of pancreatic cancer: the VITamins and Lifestyle study.” British journal of cancer.
  53. Barbato, J.E. and Tzeng, E., 2004. Nitric oxide and arterial disease. Journal of vascular surgery, 40(1), pp.187-193.
  54. Kostov, K., 2019. Effects of magnesium deficiency on mechanisms of insulin resistance in type 2 diabetes: focusing on the processes of insulin secretion and signaling. International journal of molecular sciences, 20(6), p.1351.
  55. Orgel, E. and Mittelman, S.D., 2013. The links between insulin resistance, diabetes, and cancer. Current diabetes reports, 13(2), pp.213-222.
  56. Fernández, M.F., Reina-Pérez, I., Astorga, J.M., Rodríguez-Carrillo, A., Plaza-Díaz, J. and Fontana, L., 2018. Breast cancer and its relationship with the microbiota. International journal of environmental research and public health, 15(8), p.1747.
  57. LeBeau, A.M., Kostova, M., Craik, C.S. and Denmeade, S.R., 2010. Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer. Biological chemistry, 391(4), pp.333-343.
  58. Nielsen, F.H. and Meacham, S.L., 2011. Growing evidence for human health benefits of boron. Journal of Evidence-Based Complementary & Alternative Medicine, 16(3), pp.169-180.
  59. Scorei, I.R., 2011. Boron compounds in the breast cancer cells chemoprevention and chemotherapy (p. 540). ISBN 978-953-307-776-5, Hard Cover, InTech Publication.
  60. Gallo, L., Pecoraro, S., Sarnacchiaro, P., Silvani, M. and Antonini, G., 2020. The Daily Therapy With L-Arginine 2,500 mg and Tadalafil 5 mg in Combination and in Monotherapy for the Treatment of Erectile Dysfunction: A Prospective, Randomized Multicentre Study. Sexual Medicine.
  61. Ignarro, L.J., Byrns, R.E., Sumi, D., de Nigris, F. and Napoli, C., 2006. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric oxide, 15(2), pp.93-102.
  62. Kijima, I., Phung, S., Hur, G., Kwok, S.L. and Chen, S., 2006. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression. Cancer research, 66(11), pp.5960-5967.
  63. Otake, Y., Nolan, A.L., Walle, U.K. and Walle, T., 2000. Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells. The Journal of steroid biochemistry and molecular biology, 73(5), pp.265-270.
  64. Daumerie, C. and Henquin, J.C., 1982. Acute effects of guar gum on glucose tolerance and intestinal absorption of nutrients in rats. Diabete & metabolisme, 8(1), p.1.
  65. Dreosti, I.E., 1995. Magnesium status and health. Nutrition reviews, 53(9), p.S23.

Dr. Rodney Lopez

MBBS (Usyd) GradCertNutriMed (RMIT)

We value feedback and suggestion. We also welcome Allied Health and Medical Practitioners to join our nutrition-focused team. Please contact us

Contact Us Find a Practitioner Product Queries Disclaimer